KRTAP19-5
gene geneOn this page
Also known as KAP19.5
Summary
KRTAP19-5 (keratin associated protein 19-5, HGNC:18940) is a protein-coding gene on chromosome 21q22.11, encoding Keratin-associated protein 19-5 (Q3LI72). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 337972 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 13 total
- MANE Select transcript:
NM_181611
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18940 |
| Approved symbol | KRTAP19-5 |
| Name | keratin associated protein 19-5 |
| Location | 21q22.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP19.5 |
| Ensembl gene | ENSG00000186977 |
| Ensembl biotype | protein_coding |
| Entrez | 337972 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334151
RefSeq mRNA: 1 — MANE Select: NM_181611
NM_181611
CCDS: CCDS13597
Canonical transcript exons
ENST00000334151 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001338619 | 30501657 | 30502141 |
Expression profiles
Bgee: expression breadth broad, 33 present calls, max score 85.40.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1969 / max 66.9101, expressed in 25 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190127 | 0.1969 | 25 |
Top tissues by expression
101 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.40 | gold quality |
| sural nerve | UBERON:0015488 | 42.89 | silver quality |
| granulocyte | CL:0000094 | 42.33 | silver quality |
| bone marrow cell | CL:0002092 | 38.79 | gold quality |
| skin of abdomen | UBERON:0001416 | 38.16 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| right lung | UBERON:0002167 | 37.12 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| zone of skin | UBERON:0000014 | 36.09 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skin of leg | UBERON:0001511 | 34.77 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 33.09 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| liver | UBERON:0002107 | 29.99 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.27 | silver quality |
| leukocyte | CL:0000738 | 28.63 | silver quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| monocyte | CL:0000576 | 27.90 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| right lobe of liver | UBERON:0001114 | 27.41 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| muscle of leg | UBERON:0001383 | 26.92 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gastrocnemius | UBERON:0001388 | 26.16 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The KRTAP19-5 promoter is activated by Trichostatin A (TSA) treatment and by serum depletion according to promoter reporter assays in HEK 293 cells. (PMID:20494980)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Keratin-associated protein 19-5 — Q3LI72 (reviewed: Q3LI72)
All UniProt accessions (1): Q3LI72
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 19 family.
RefSeq proteins (1): NP_853642* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR021743 | KRTAP_type8/19/20/21/22 | Family |
| IPR051528 | KRTAP_type_19 | Family |
Pfam: PF11759
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3LI72-F1 | 49.63 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 38 (showing top):
MARTINEZ_RB1_TARGETS_DN, chr21q22, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, E4BP4_01, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MARTINEZ_RB1_AND_TP53_TARGETS_DN, GSE17721_POLYIC_VS_CPG_16H_BMDC_UP, GSE17721_LPS_VS_CPG_2H_BMDC_UP, NOTCH3_TARGET_GENES, GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN, GSE18148_CBFB_KO_VS_WT_TREG_UP, YATTNATC_UNKNOWN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
196 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP19-5 | KRTAP10-11 | P60412 | 580 |
| KRTAP19-5 | TAFA3 | Q7Z5A8 | 578 |
| KRTAP19-5 | KRTAP13-2 | Q52LG2 | 575 |
| KRTAP19-5 | KRTAP10-5 | P60370 | 544 |
| KRTAP19-5 | KRTAP10-7 | P60409 | 526 |
| KRTAP19-5 | NT5DC3 | Q86UY8 | 514 |
| KRTAP19-5 | NCLN | Q969V3 | 480 |
| KRTAP19-5 | KRTAP19-1 | Q8IUB9 | 480 |
| KRTAP19-5 | KRTAP20-2 | Q3LI61 | 478 |
| KRTAP19-5 | FAXDC2 | Q96IV6 | 447 |
| KRTAP19-5 | KRTAP7-1 | Q8IUC3 | 429 |
| KRTAP19-5 | KRTAP8-1 | Q8IUC2 | 416 |
| KRTAP19-5 | LCE2C | Q5TA81 | 393 |
| KRTAP19-5 | ARPP21 | Q9UBL0 | 391 |
| KRTAP19-5 | GLRA1 | P23415 | 380 |
| KRTAP19-5 | LCE2A | Q5TA79 | 380 |
IntAct
351 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAGED1 | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.810 |
| KRTAP19-5 | MAGED1 | psi-mi:“MI:0915”(physical association) | 0.810 |
| KRTAP19-5 | VAC14 | psi-mi:“MI:0915”(physical association) | 0.720 |
| DAZAP2 | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP19-5 | RHOXF2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP19-5 | DAZAP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| RHOXF2 | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VAC14 | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP19-5 | ATN1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| RBPMS | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.610 |
| KRTAP19-5 | RBPMS | psi-mi:“MI:0915”(physical association) | 0.610 |
| KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP19-5 | DAB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-5 | PSMA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CAMK2B | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HEL-S-101 | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PSMA3 | KRTAP19-5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-5 | CAMK2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP19-5 | HEL-S-101 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (103): KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Affinity Capture-MS), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid), KRTAP19-5 (Two-hybrid)
ESM2 similar proteins: H2A0M6, O08632, O08633, O08640, P02448, P04459, P05685, P08826, P25692, P82170, P83358, Q02957, Q02958, Q28580, Q3LHN2, Q3LI54, Q3LI58, Q3LI59, Q3LI60, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI68, Q3LI70, Q3LI72, Q3LI73, Q3LI77, Q3MIV0, Q3SYF9, Q4W7G7, Q4W7G8, Q4W7G9, Q4W7H0, Q4W7H1, Q6F4C6, Q6R645, Q7Z4W3, Q8C1I6
Diamond homologs: O08632, Q3LI72, Q3LI73, Q7Z4W3, Q3LHN2, Q3LI60, Q3LI61, Q3LI63, Q3SYF9, Q3LI70, Q8IUB9, Q925H2, Q925H7, Q925I0, Q99NG9, Q925H6, Q8C1I6, Q3LI54
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 92 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 6 | 8.2× | 3e-03 |
| Ub-specific processing proteases | 5 | 6.5× | 7e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
94 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:30502043:T:TA | donor_gain | 0.8500 |
| 21:30502064:T:TA | donor_gain | 0.8000 |
| 21:30502048:AG:A | donor_gain | 0.7700 |
| 21:30502049:G:C | donor_gain | 0.7600 |
| 21:30502024:AG:A | donor_gain | 0.6800 |
| 21:30502025:G:C | donor_gain | 0.6800 |
| 21:30501961:AG:A | donor_gain | 0.6700 |
| 21:30502007:T:TA | donor_gain | 0.6600 |
| 21:30502024:AGC:A | donor_gain | 0.6500 |
| 21:30502018:AG:A | donor_gain | 0.6400 |
| 21:30501938:T:TA | donor_gain | 0.6300 |
| 21:30501934:AG:A | donor_gain | 0.6200 |
| 21:30502076:G:A | donor_gain | 0.6200 |
| 21:30502059:AGG:A | donor_gain | 0.6100 |
| 21:30501934:AGCCT:A | donor_gain | 0.5900 |
| 21:30501955:AT:A | donor_gain | 0.5800 |
| 21:30501900:C:CA | donor_gain | 0.5700 |
| 21:30501961:AGCCT:A | donor_gain | 0.5700 |
| 21:30501965:T:TA | donor_gain | 0.5600 |
| 21:30502019:G:C | donor_gain | 0.5600 |
| 21:30501935:G:C | donor_gain | 0.5500 |
| 21:30501896:T:TA | donor_gain | 0.5400 |
| 21:30501881:T:TA | donor_gain | 0.5200 |
| 21:30501956:T:C | donor_gain | 0.5200 |
| 21:30502054:AGC:A | donor_gain | 0.5200 |
| 21:30502039:AG:A | donor_gain | 0.5100 |
| 21:30502054:AG:A | donor_gain | 0.5000 |
| 21:30501745:TAA:T | donor_gain | 0.4900 |
| 21:30501746:AAA:A | donor_gain | 0.4900 |
| 21:30501920:G:C | donor_gain | 0.4900 |
AlphaMissense
436 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:30501887:G:C | F68L | 0.832 |
| 21:30501887:G:T | F68L | 0.832 |
| 21:30501889:A:G | F68L | 0.832 |
| 21:30501941:G:C | F50L | 0.780 |
| 21:30501941:G:T | F50L | 0.780 |
| 21:30501943:A:G | F50L | 0.780 |
| 21:30501878:A:C | F71L | 0.749 |
| 21:30501878:A:T | F71L | 0.749 |
| 21:30501880:A:G | F71L | 0.749 |
| 21:30501995:G:C | F32L | 0.746 |
| 21:30501995:G:T | F32L | 0.746 |
| 21:30501997:A:G | F32L | 0.746 |
| 21:30502037:G:C | F18L | 0.732 |
| 21:30502037:G:T | F18L | 0.732 |
| 21:30502039:A:G | F18L | 0.732 |
dbSNP variants (sampled 300 via entrez): RS1000151772 (21:30503299 C>A), RS1001059940 (21:30503333 C>A,T), RS1001600717 (21:30501352 G>A), RS1003455245 (21:30501434 T>C,G), RS1004256135 (21:30501386 A>G,T), RS1004828180 (21:30503707 T>A), RS1004949323 (21:30504101 T>A,C), RS1007243095 (21:30503683 C>G), RS1007613746 (21:30501796 C>T), RS1007879320 (21:30503377 G>A,T), RS1008673456 (21:30503329 C>A,T), RS1009033100 (21:30503093 G>A), RS1010711580 (21:30501816 G>A,C), RS1011081564 (21:30502522 T>A,C), RS1011416357 (21:30501381 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| afuresertib | decreases expression | 1 |
| clothianidin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.